Latest Rheumatology News
Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis
posted January 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
PCP-Specialist Cotraining Improves Patient Experiences
posted January 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Women With Employer Insurance More Likely to Report Unaffordability of Care
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Nurse-Driven Protocol Ups Pneumococcal Vaccination Rates
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer Related Articles
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Exposure to Air Pollutants Linked to Increased RA Disease Activity Rheumatology Conference Highlights
Rheumatology Monthly Briefings
Rheumatology Conference News
Stay Connected
